Factors associated with early recurrence after curative surgery for gastric cancer

Table 1 Initial recurrence patterns in the 194 patients with recurrence n (%)

Pattern	Total recurrence	Early recurrence	Late recurrence	P value
	n = 194 (100.0)	n = 129 (66.5)	n = 65 (33.5)
Hematogenous recurrence	77 (39.7)	56 (43.4)	21 (32.3)	0.136
Liver	55 (28.4)	42 (32.6)	13 (20.0)	0.067
Lung	16 (8.2)	10 (7.8)	6 (9.2)	0.724
Bone	14 (7.2)	8 (6.2)	6 (9.2)	0.442
Brain	3 (1.5)	2 (1.6)	1 (1.5)	0.995
Locoregional recurrence	99 (51.0)	68 (52.7)	31 (47.7)	0.509
Remnant stomach	10 (5.2)	6 (4.7)	4 (6.2)	0.734
Anastomosis	32 (16.5)	25 (19.4)	7 (10.8)	0.127
Perigastric area	40 (20.6)	27 (20.9)	13 (20.0)	0.880
Peripancreatic area	13 (6.7)	10 (7.8)	3 (4.6)	0.410
Abdominal wall	2 (1.6)	2 (1.9)	0 (0.0)	0.313
Local lymph node	34 (17.5)	27 (20.9)	7 (10.8)	0.079
Peritoneal recurrence	86 (44.3)	59 (45.7)	27 (41.5)	0.579
Distant lymphatic recurrence	11 (5.7)	7 (5.4)	4 (6.2)	1.000
Virchow’s node	6 (3.1)	4 (3.1)	2 (3.1)	1.000
Inguinal lymph node	1 (0.5)	0 (0.0)	1 (1.5)	0.335
Mediastinal lymph node	3 (1.5)	2 (1.6)	1 (1.5)	1.000
Para-aortic lymph node	2 (1.0)	2 (1.6)	0 (0.0)	0.552

P values were evaluated by Pearson’s χ² test or Fisher’s exact test, as appropriate. Some patients experienced initial recurrence at multiple sites.